Barclays
LH icon

Barclays’s Labcorp LH Stock Holding History

Barclays’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.4M Sell
143,744
-57,599
-29% -$15.6M 0.01% 823
2025
Q4 		$50.5M Sell
201,343
-13,188
-6% -$3.5M 0.01% 772
2025
Q3 		$61.6M Sell
214,531
-83,527
-28% -$22.4M 0.01% 670
2025
Q2 		$78.2M Sell
298,058
-84,785
-22% -$20.6M 0.02% 553
2025
Q1 		$89.1M Buy
382,843
+92,940
+32% +$22.6M 0.03% 458
2024
Q4 		$66.5M Sell
289,903
-330,818
-53% -$75.9M 0.02% 553
2024
Q3 		$139M Buy
620,721
+65,356
+12% +$14.4M 0.04% 339
2024
Q2 		$113M Buy
555,365
+73,086
+15% +$14.9M 0.03% 351
2024
Q1 		$105M Buy
482,279
+148,965
+45% +$32.8M 0.04% 369
2023
Q4 		$75.8M Buy
333,314
+55,461
+20% +$11.7M 0.03% 506
2023
Q3 		$55.9M Buy
277,853
+11,156
+4% +$2.35M 0.03% 452
2023
Q2 		$55.3M Buy
266,697
+16,162
+6% +$3.14M 0.04% 417
2023
Q1 		$49.4M Sell
250,535
-30,320
-11% -$6.24M 0.02% 466
2022
Q4 		$56.8M Buy
280,855
+64,295
+30% +$12.6M 0.03% 440
2022
Q3 		$38.1M Sell
216,560
-12,596
-5% -$2.58M 0.04% 393
2022
Q2 		$46.1M Sell
229,156
-315,644
-58% -$67.3M 0.03% 424
2022
Q1 		$123M Buy
544,800
+295,702
+119% +$69.5M 0.1% 202
2021
Q4 		$67.2M Sell
249,098
-128,202
-34% -$31.7M 0.03% 468
2021
Q3 		$91.2M Buy
377,300
+78,836
+26% +$19.9M 0.04% 348
2021
Q2 		$70.7M Buy
298,464
+155,817
+109% +$35.5M 0.03% 393
2021
Q1 		$31.3M Buy
142,647
+25,906
+22% +$5.2M 0.02% 618
2020
Q4 		$20.4M Buy
116,741
+15,463
+15% +$2.67M 0.01% 829
2020
Q3 		$16.4M Buy
101,278
+26,342
+35% +$4.17M 0.01% 830
2020
Q2 		$10.7M Sell
74,936
-14,474
-16% -$2M 0.01% 926
2020
Q1 		$9.71M Sell
89,410
-119,647
-57% -$17.2M 0.01% 1005
2019
Q4 		$30.4M Buy
209,057
+3,170
+2% +$458K 0.02% 734
2019
Q3 		$29.7M Sell
205,887
-18,950
-8% -$2.77M 0.02% 677
2019
Q2 		$33.4M Buy
224,837
+33,870
+18% +$4.73M 0.02% 649
2019
Q1 		$25.1M Buy
190,967
+6,422
+3% +$791K 0.02% 730
2018
Q4 		$20M Sell
184,545
-1,828
-1% -$245K 0.02% 744
2018
Q3 		$27.8M Buy
186,373
+16,243
+10% +$2.47M 0.02% 691
2018
Q2 		$26.2M Sell
170,130
-168,734
-50% -$25.5M 0.02% 648
2018
Q1 		$47.1M Sell
338,864
-137,444
-29% -$20.2M 0.04% 443
2017
Q4 		$65.3M Buy
476,308
+356,297
+297% +$47.1M 0.05% 302
2017
Q3 		$15.6M Sell
120,011
-260,199
-68% -$34.7M 0.02% 782
2017
Q2 		$50.3M Buy
380,210
+255,948
+206% +$31.3M 0.05% 279
2017
Q1 		$15.3M Sell
124,262
-21,720
-15% -$2.57M 0.02% 668
2016
Q4 		$16.1M Buy
145,982
+36,343
+33% +$4.04M 0.02% 696
2016
Q3 		$12.9M Sell
109,639
-14,878
-12% -$1.75M 0.01% 730
2016
Q2 		$13.9M Sell
124,517
-161,635
-56% -$17.4M 0.02% 674
2016
Q1 		$28.8M Buy
286,152
+184,595
+182% +$17.7M 0.04% 371
2015
Q4 		$10.7M Buy
101,557
+5,323
+6% +$549K 0.01% 854
2015
Q3 		$8.93M Sell
96,234
-48,456
-33% -$5.01M 0.01% 1008
2015
Q2 		$15M Buy
144,690
+12,270
+9% +$1.28M 0.02% 807
2015
Q1 		$14.3M Sell
132,420
-71,609
-35% -$7.36M 0.02% 870
2014
Q4 		$18.8M Buy
204,029
+148,490
+267% +$13.1M 0.02% 798
2014
Q3 		$4.82M Sell
55,539
-20,695
-27% -$1.87M ﹤0.01% 1812
2014
Q2 		$6.68M Sell
76,234
-31,492
-29% -$2.73M 0.01% 1485
2014
Q1 		$9.07M Sell
107,726
-52,255
-33% -$4.17M 0.01% 1215
2013
Q4 		$12.5M Sell
159,981
-33,508
-17% -$2.86M 0.01% 1087
2013
Q3 		$16.5M Buy
193,489
+95,457
+97% +$8.04M 0.02% 794
2013
Q2 		$8.43M Buy
+98,032
New +$8.14M 0.01% 1205

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays's LH Position: Q1 2026 in Review

Barclays reduced its Labcorp (LH) stake by 29% in Q1 2026, selling an estimated $15.6M and leaving 143,744 shares worth $38.4M. The position accounts for 0.01% of the portfolio, ranked #823.

Barclays first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $139M in Q3 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Barclays held 143,744 shares of Labcorp worth $38.4M as of Q1 2026.
  • Barclays sold 57,599 Labcorp shares in Q1 2026, an estimated $15.6M.
  • Labcorp made up 0.01% of Barclays's portfolio in Q1 2026, its #823 holding.
  • Barclays first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Labcorp position peaked at $139M in Q3 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.